MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Sphingosine-1-phosphate, motor severity and progression in Parkinson’s disease (MARK-PD)

    C. Choe, C. Englisch, L. Niemann, S. Lezius, M. von Lucadou, K. Marmann, R. Böger, S. Peine, G. Daum, C. Gerloff, E. Schwedhelm (Hamburg, Germany)

    Objective: We assessed the association of serum sphingosine-1-phosphate (S1P) levels with motor and cognitive symptoms in patients with Parkinson’s disease (PD). Background: Treatment with sphingosine-1-phosphate…
  • MDS Virtual Congress 2021

    The Prodromal PD study – multiple biomarkers for early diagnosis?

    P. de Roos, D. Nyholm, M. Ingelsson (Uppsala, Sweden)

    Objective: The study aims to deepen our understanding of the prodromal phase of Parkinson’s disease (PD) Background: At the time of PD diagnosis, nigrostriatal degeneration…
  • MDS Virtual Congress 2021

    GBA Mutation Accumulates Higher Alpha-Synuclein in Alpha-Synucleinopathies

    T. Eid (London, United Kingdom)

    Objective: To investigate whether post-translational modifications of α-synuclein will give rise to species that differ between PD cases with N370S GBA mutation and WT-PD. Background:…
  • MDS Virtual Congress 2021

    Comparative score on the MDS-UPDRS scale I, II and IV in patients with Parkinson disease with and without cardiovascular risk factors.

    H. Gonzalez-Usigli, A. Gonzalez-Vazquez, J. Garcia-Rivera, O. Padila-Delatorre, A. Leon-Gil, H. Gonzalez-Rodriguez (Guadalajara, Mexico)

    Objective: To find any relationship between cardiovascular risk factors such as diabetes mellitus, hypertension or both and worse state in patient with PD measured with…
  • MDS Virtual Congress 2021

    HbA1c correlates with motor and cognitive outcome scores in patients with Parkinson’s disease and type 2 diabetes.

    B. Huxford, T. Haque, A. Joseph, C. Simonet, D. Gallagher, C. Budu, R. Dobson, A. Noyce (London, United Kingdom)

    Objective: The objective of this study was to investigate the relationship between glycated haemoglobin (HbA1c) levels in blood and clinical outcomes (MDS-UPDRS III, MDS-UPDRS IV,…
  • MDS Virtual Congress 2021

    Gut, nasal and oral dysbiosis in Parkinson’s disease

    S. Jo, W. Kang, YS. Hwang, SH. Lee, SJ. Chung (Seoul, Republic of Korea)

    Objective: We aimed to identify the nasal, oral, and gut microbiota dysbiosis associated with the presence and clinical manifestations of Parkinson’s disease (PD) using 16s…
  • MDS Virtual Congress 2021

    Does the observation of an action inserted in an emotion-enriched context influence cortical excitability in patients with Parkinson’s disease?

    G. Lagravinese, E. Pelosin, A. Bisio, G. Bonassi, M. Putzolu, A. Botta, C. Cosentino, C. Ponte, S. Mezzarobba, L. Avanzino (Genoa, Italy)

    Objective: To explore the effect induced by the observation of a grasping movement, inserted in different emotional contexts, on cortico-spinal excitability, in healthy people and…
  • MDS Virtual Congress 2021

    Decreased mesencephalic locomotor region activation explains loss of presynaptic inhibition during step initiation in people with Parkinson´s disease with freezing of gait

    J. Lira, C. Ugrinowitsch, M. Nucci, D. Coelho, E. Barbosa, L. Teixeira, E. Júnior, F. Horak, M. Mancini, C. Batista (São Paulo, Brazil)

    Objective: To investigate if decreased mesencephalic locomotor activation (MRL) activation during step initiation in an-event related fMRI protocol would explain the loss of presynaptic inhibition…
  • MDS Virtual Congress 2021

    Total cerebral small vessel score associated with Hoehn and Yahr stages in Parkinson’s disease

    X. Ma, W. Su, H. Chen (Beijing, China)

    Objective: To evaluate the total cerebral small vessel disease (CSVD) score in patients with Parkinson’s disease at different stages and its related factors. Background: Parkinson’s…
  • MDS Virtual Congress 2021

    Evaluation of Acoustic Features of Speech for Monitoring Parkinson’s Disease Progression

    M. Magee, J. Tamplin, M. Morris, C. Marigliani, F. Baker, A. Tsanas, G. Noffs, A. Vogel (Parkville, Australia)

    Objective: Examine the temporal stability (i.e., repeatability) and sensitivity (i.e., change) of acoustic features of speech in people with Parkinson's Disease (PWP). Background: Voice and…
  • « Previous Page
  • 1
  • …
  • 1001
  • 1002
  • 1003
  • 1004
  • 1005
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley